In a new study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25), South Korean researchers report that for patients at high risk for bleeding following stent ...

Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...

A step forward in de-escalating treatment The evolution of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has been shaped by the continuous challenge of balancing ...

In 43% of patients, multiple prior stents were present at the site of the target lesion ... and 84% and 68% were still on dual antiplatelet therapy (DAPT), respectively. TLR was less frequent in the ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with ...